We also identified a number of additional differentiation, angiogenic and receptor tyrosine kinase molecules, which were downmodulated following the silencing of MDA-9/Syntenin in the HNSCC cells. The gene discussed is NTRK1; the disease is head and neck squamous cell carcinoma.